101 related articles for article (PubMed ID: 8569707)
1. The binding of propranolol at 5-hydroxytryptamine1D beta T355N mutant receptors may involve formation of two hydrogen bonds to asparagine.
Glennon RA; Dukat M; Westkaemper RB; Ismaiel AM; Izzarelli DG; Parker EM
Mol Pharmacol; 1996 Jan; 49(1):198-206. PubMed ID: 8569707
[TBL] [Abstract][Full Text] [Related]
2. 2-(1-Naphthyloxy)ethylamines with enhanced affinity for human 5-HT1D beta (h5-HT1B) serotonin receptors.
Ismaiel AM; Dukat M; Law H; Kamboj R; Fan E; Lee DK; Mazzocco L; Buekschkens D; Teitler M; Pierson ME; Glennon RA
J Med Chem; 1997 Dec; 40(26):4415-9. PubMed ID: 9435911
[TBL] [Abstract][Full Text] [Related]
3. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
[TBL] [Abstract][Full Text] [Related]
4. Amino acid substitutions at position 312 in the seventh hydrophobic segment of the beta 2-adrenergic receptor modify ligand-binding specificity.
Suryanarayana S; Kobilka BK
Mol Pharmacol; 1993 Jul; 44(1):111-4. PubMed ID: 8101966
[TBL] [Abstract][Full Text] [Related]
5. Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors.
Glennon RA; Hong SS; Bondarev M; Law H; Dukat M; Rakhi S; Power P; Fan E; Kinneau D; Kamboj R; Teitler M; Herrick-Davis K; Smith C
J Med Chem; 1996 Jan; 39(1):314-22. PubMed ID: 8568822
[TBL] [Abstract][Full Text] [Related]
6. A single point mutation increases the affinity of serotonin 5-HT1D alpha, 5-HT1D beta, 5-HT1E and 5-HT1F receptors for beta-adrenergic antagonists.
Adham N; Tamm JA; Salon JA; Vaysse PJ; Weinshank RL; Branchek TA
Neuropharmacology; 1994; 33(3-4):387-91. PubMed ID: 7984276
[TBL] [Abstract][Full Text] [Related]
7. Study of the interaction between aryloxypropanolamines and Asn386 in helix VII of the human 5-hydroxytryptamine1A receptor.
Kuipers W; Link R; Standaar PJ; Stoit AR; Van Wijngaarden I; Leurs R; Ijzerman AP
Mol Pharmacol; 1997 May; 51(5):889-96. PubMed ID: 9145928
[TBL] [Abstract][Full Text] [Related]
8. Identification of a single amino acid residue responsible for the binding of a class of beta-adrenergic receptor antagonists to 5-hydroxytryptamine1A receptors.
Guan XM; Peroutka SJ; Kobilka BK
Mol Pharmacol; 1992 Apr; 41(4):695-8. PubMed ID: 1349154
[TBL] [Abstract][Full Text] [Related]
9. Mutagenesis of important amino acid reveals unconventional homologous internalization of beta(1)-adrenergic receptor.
Hossain M; Rashid M; Bhuiyan MA; Nakamura T; Ozaki M; Nagatomo T
Life Sci; 2009 Aug; 85(7-8):339-44. PubMed ID: 19580817
[TBL] [Abstract][Full Text] [Related]
10. A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors.
Oksenberg D; Marsters SA; O'Dowd BF; Jin H; Havlik S; Peroutka SJ; Ashkenazi A
Nature; 1992 Nov; 360(6400):161-3. PubMed ID: 1436092
[TBL] [Abstract][Full Text] [Related]
11. Modified ligand binding to the naturally occurring Cys-124 variant of the human serotonin 5-HT1B receptor.
Brüss M; Bönisch H; Bühlen M; Nöthen MM; Propping P; Göthert M
Pharmacogenetics; 1999 Feb; 9(1):95-102. PubMed ID: 10208648
[TBL] [Abstract][Full Text] [Related]
12. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.
Hirst WD; Abrahamsen B; Blaney FE; Calver AR; Aloj L; Price GW; Medhurst AD
Mol Pharmacol; 2003 Dec; 64(6):1295-308. PubMed ID: 14645659
[TBL] [Abstract][Full Text] [Related]
13. Role of threonine 342 in helix 7 of the 5-hydroxytryptamine type 1D receptor in ligand binding: an indirect mechanism for receptor selectivity.
Smolyar A; Osman R
Mol Pharmacol; 1993 Oct; 44(4):882-5. PubMed ID: 8232238
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for enantiomer binding and separation of a common beta-blocker: crystal structure of cellobiohydrolase Cel7A with bound (S)-propranolol at 1.9 A resolution.
Ståhlberg J; Henriksson H; Divne C; Isaksson R; Pettersson G; Johansson G; Jones TA
J Mol Biol; 2001 Jan; 305(1):79-93. PubMed ID: 11114249
[TBL] [Abstract][Full Text] [Related]
15. A molecular model of agonist and nonpeptide antagonist binding to the human V(1) vascular vasopressin receptor.
Thibonnier M; Coles P; Conarty DM; Plesnicher CL; Shoham M
J Pharmacol Exp Ther; 2000 Jul; 294(1):195-203. PubMed ID: 10871312
[TBL] [Abstract][Full Text] [Related]
16. Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6.
Ellis SW; Hayhurst GP; Lightfoot T; Smith G; Harlow J; Rowland-Yeo K; Larsson C; Mahling J; Lim CK; Wolf CR; Blackburn MG; Lennard MS; Tucker GT
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):565-71. PubMed ID: 10642515
[TBL] [Abstract][Full Text] [Related]
17. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.
Minami M; Nakagawa T; Seki T; Onogi T; Aoki Y; Katao Y; Katsumata S; Satoh M
Mol Pharmacol; 1996 Nov; 50(5):1413-22. PubMed ID: 8913373
[TBL] [Abstract][Full Text] [Related]
18. The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D beta receptor.
Adham N; Romanienko P; Hartig P; Weinshank RL; Branchek T
Mol Pharmacol; 1992 Jan; 41(1):1-7. PubMed ID: 1732716
[TBL] [Abstract][Full Text] [Related]
19. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional models for agonist and antagonist complexes with beta 2 adrenergic receptor.
Kontoyianni M; DeWeese C; Penzotti JE; Lybrand TP
J Med Chem; 1996 Oct; 39(22):4406-20. PubMed ID: 8893835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
